The revisions signal a shift toward looking at MS more as a biologically based disease, noted Xavier Montalban, MD, PhD, of ...

Researchers have identified biomarkers that can predict disease progression in multiple sclerosis, which could lead to the ...

Relapsing-remitting multiple sclerosis is a type of neurological disease caused by the breakdown of a protective nerve ...

MS experts are recommending updates to the 2017 McDonald diagnostic criteria that aim to make diagnosis easier, faster and more accurate.

Rutgers Health researchers will enroll primary or secondary progressive multiple sclerosis (p-MS) patients to see if an ...

You've got a lot of them, everything from disease-modifying therapies and drugs that help manage symptoms to rehabilitation ...

After years of caring for others, Auckland nurse Zazi Gohar faced her own health crisis when she was diagnosed with multiple ...

"Those with the highest burden of comorbidity had over a 30% increased risk of having disability worsening," Salter said. "In ...

Available disease-modifying therapies can prevent relapses and relapse-associated worsening in people with multiple sclerosis by targeting autoimmunity through various mechanisms. However, these ...

Derek Stefureac — diagnosed with multiple sclerosis in 2011 — completed his audacious goal of running a marathon on all seven ...

High-dose cholecalciferol (vitamin D) is safe and can nearly double the time it takes for clinically isolated syndrome to ...

A separate US-based single-arm OLIKOS Phase IIIb study showed that at 12 months, all clinically stable RMS patients who switched from intravenous (IV) anti-CD20 therapy to Kesimpta showed no new ...